Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)

HKG:2659 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	0.28	0.21	0.15
Net Debt / Equity Ratio	-0.23	-0.32	-0.28
Net Debt / EBITDA Ratio	0.75	0.97	1.46
Net Debt / FCF Ratio	0.84	0.95	0.77
Asset Turnover	-	0.01	-
Inventory Turnover	-	0.18	-
Quick Ratio	1.58	2.68	2.22
Current Ratio	2.09	3.39	2.49
Return on Equity (ROE)	-	-41.77%	-
Return on Assets (ROA)	-	-19.23%	-
Return on Capital Employed (ROCE)	-28.00%	-30.80%	-20.20%
Buyback Yield / Dilution	-	-5.82%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.